Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,721,439
-$893,790 QoQ
Shares Held
2,749,087
-9.4% QoQ
Ownership
3.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 86 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SABS Over Time

Shares Held

Position Value (USD)

Derivatives in SABS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
62,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. SABS ranks #103 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SABS

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 SABSW 62,500
2026-06-30 $10,721,439 2,749,087
2026-04-24 $12,596,001 3,432,153
2026-03-31 SABSW 62,500
2026-03-31 $11,615,229 3,032,697
2025-12-31 SABSW 62,500
2025-12-31 $1,212,096 324,090
2025-09-30 SABSW 62,500
2025-06-30 SABSW 62,500
2025-03-31 SABSW 62,500
2025-03-31 $22,237 16,351
2024-12-31 SABSW 62,500
2024-12-31 $111,585 29,411
2024-09-30 SABSW 62,500
2024-09-30 $140,254 51,946
2024-06-30 SABSW 62,500
2024-06-30 $163,630 52,784
2024-03-31 SABSW 62,500
2024-03-31 $245,387 54,050
2023-12-31 SABSW 62,500
2023-09-30 SABSW 62,500
2023-06-30 SABSW 62,500
2023-03-31 SABSW 62,500
2022-12-31 SABSW 62,500
2022-09-30 SABSW 62,500
2022-09-30 $27,021 38,547
2022-06-30 SABSW 62,500
2022-06-30 $93,119 64,220
2022-03-31 SABSW 62,500
2021-12-31 SABSW 62,500
2021-09-30 BCYP 191,311
2021-06-30 BCYP 36,655